Overview

Detailed Summary

Tatva Chintan Pharma Chem Limited is a globally recognized specialty chemical manufacturer. Its core business lies in developing and distributing specialty chemicals like Phase Transfer Catalysts, Structure Directing Agents, and Electrolyte Salts.
In Q3 FY26, the company exhibited significant financial improvement with a 53% revenue growth from the previous year and a dramatic 10,889% increase in PAT.
Tatva Chintan's focus on 'green' chemistry, employing processes like electrolysis and continuous flow chemistry, underscores its commitment to sustainable practices.
The company benefits from a wide international reach, exporting over 62% of its products to countries including the USA, UK, and Germany.
Tatva Chintan's R&D capabilities are robust, with a DSIR-recognized facility and significant investments, facilitating innovative product development and process enhancements.

Sector: Chemicals
Industry: Chemicals - Speciality - Medium / Small
Market Cap: 2,737 Cr
Volatility: High Risk
P/E Ratio: 80.0
Industry P/E: 25.5
PEG Ratio: 2.4
P/B Ratio: 3.6
52W High: 1,603.60
52W Low: 610.00

Sales CAGR

1Y: -2.74%
3Y: -5.03%
5Y: 7.62%
10Y: —

Profit CAGR

1Y: -81.19%
3Y: -84.95%
5Y: -60.72%
10Y: —

ROE

TTM: 2.35%
3Y: 3.59%
5Y: 8.42%
10Y: —

ROCE

TTM: 3.14%
3Y: 4.98%
5Y: 10.22%
10Y: —

Technicals

Oscillators

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Forecasts

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
FOSECOIND	5354.25	4,036 Cr	52.83	3.89	0.47	8.43	12.26	—
TATVA	1169.90	2,737 Cr	83.50	3.63	0.09	2.35	3.14	3.61
FCL	22.99	2,650 Cr	26.43	3.13	0.35	12.63	16.75	11.55
PLATIND	207.00	1,139 Cr	26.27	2.78	0.00	10.34	13.89	8.29
PAUSHAKLTD	436.00	1,074 Cr	29.52	2.24	0.57	9.47	10.40	5.87
JYOTIRES	837.80	1,001 Cr	14.70	4.24	1.08	29.00	38.69	18.24
SUNSHIEL	815.30	717 Cr	28.77	6.56	0.26	19.87	19.34	8.84

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	97	84	98	105	83	86	108	117	124	131
Expenses	76	73	83	93	78	79	99	100	101	106
Operating Profit	20	11	16	13	5.58	7.06	8.95	17	22	25
OPM %	20.95	13.05	15.88	11.97	6.68	8.22	8.30	14.82	17.99	19.40
Other Income	0.76	1.21	4.53	1.17	0.38	0.04	0.72	1.16	1.01	1.73
Interest	3.01	0.38	0.21	0.31	0.17	0.42	0.39	0.41	0.51	0.49
Depreciation	6.78	6.58	6.23	6.67	6.81	6.92	7.26	8.97	9.05	9.07
Profit Before Tax	11	5.24	14	6.81	-1.02	-0.24	2.03	9.10	14	18
Tax %	30.60	34.16	29.80	23.49	35.29	154.17	49.26	26.92	27.45	14.10
Net Profit	7.78	3.46	9.61	5.21	-0.66	0.14	1.03	6.65	9.92	15
EPS in Rs	3.43	1.48	4.11	2.23	-0.29	0.06	0.44	2.84	4.24	6.49

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	136	206	263	300	434	424	394	383	394
Expenses	113	173	208	234	325	363	325	349	355
Operating Profit	23	34	55	66	108	61	68	34	39
OPM %	16.89	16.38	20.88	22.12	24.96	14.30	17.33	8.94	9.87
Other Income	1.48	1.24	1.38	5.20	8.89	2.16	7.51	2.32	2.30
Interest	2.43	3.63	3.95	4.21	4.83	8.40	6.53	1.29	1.39
Depreciation	2.95	4.02	4.79	6.73	8.18	9.56	26	28	30
Profit Before Tax	19	27	48	61	104	45	44	7.58	9.87
Tax %	35.44	25.01	20.61	13.90	7.92	-1.58	30.33	24.62	27.46
Net Profit	12	21	38	52	96	45	30	5.71	7.16
EPS in Rs	—	—	—	26.01	42.99	19.44	13.08	2.44	14.01
Dividend Payout %	0.00	0.00	0.00	19.22	4.49	9.75	15.08	40.98	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	8.04	8.04	8.04	20	22	22	23	23
Reserves	51	72	110	146	451	493	714	715
Borrowings	52	71	79	90	120	170	14	36
Other Liabilities	33	36	52	59	65	74	67	61
Total Liabilities	144	188	249	315	658	759	819	836
Fixed Assets	57	67	111	120	160	196	427	526
CWIP	9.94	6.04	4.89	9.81	51	231	77	27
Investments	0.53	0.00	0.00	0.00	0.00	0.00	10	0.00
Other Assets	76	115	133	185	447	332	305	283
Total Assets	144	188	249	315	658	759	819	836

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	13	7.36	25	20	20	28	98	25
Cash from Investing Activity	-30	-17	-40	-21	-197	-101	-121	-65
Cash from Financing Activity	7.34	17	9.95	-4.71	235	38	31	17
Net Cash Flow	-10	7.99	-4.92	-5.68	59	-36	8.02	-24

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Aug 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	79.17%	75.02%	72.02%	72.02%	72.02%	72.02%	72.02%	72.02%	72.02%	72.02%	72.02%	72.02%
FIIs	3.19%	4.13%	4.41%	4.21%	3.65%	3.37%	3.33%	3.36%	3.30%	3.26%	3.39%	4.17%
DIIs	11.07%	13.85%	13.79%	13.06%	12.84%	10.63%	6.82%	6.34%	5.46%	5.11%	3.86%	3.33%
Public	6.56%	7.00%	9.78%	10.71%	11.49%	13.98%	17.82%	18.28%	19.22%	19.60%	20.73%	20.48%
Total Shareholders	70,799	71,340	74,628	74,519	73,730	73,912	79,623	79,009	78,393	76,792	73,331	68,657

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Projection

Unlock Premium Features

Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Available on Pro Plan